Oncology & Cancer
Targeted drug tagrisso could be advance against lung cancer
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
News tagged with epidermal growth factor receptor
Oncology & Cancer
Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics
Doctors typically treat people with non-small cell lung cancer, a prevalent and typically incurable type of cancer that makes up 80%-85% of lung cancers, with tyrosine kinase inhibitors, specifically epidermal growth factor ...
Apr 12, 2022
0
16
Oncology & Cancer
Tailoring lung cancer therapies to individual patients
Recent findings in the laboratory of University of Kentucky Markey Cancer Center researcher Christine Brainson, Ph.D., could lead to promising treatments for two molecular subtypes of lung cancer.
Feb 10, 2022
0
11
Oncology & Cancer
How artificial intelligence and machine learning will contribute to cancer patient care and vaccine design
Artificial intelligence/machine learning involves the development of computer systems that perform tasks that would normally require human intelligence. AI/ML is used by people every day, for example, while using smart home ...
Dec 8, 2021
0
44
Medical research
Skin stem cells get moving for enhanced skin regeneration
Although sometimes hard to accept, with aging, many things in our bodies change. One of these is the ability of the skin to regenerate. Old skin is just not as good as young skin at healing wounds. However, the molecular ...
Oct 15, 2021
0
59
Medications
Adjuvant treatment of NSCLC: Certain patients benefit from osimertinib
Osimertinib was the first drug to be approved for adjuvant treatment after complete tumor resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC). In an early benefit assessment, the German Institute ...
Oct 1, 2021
0
5
Oncology & Cancer
Novel therapy shows promise for lung cancer patients with rare EGFR mutation
Lung cancer is the leading cause of cancer death among men and women in the United States, regardless of ethnicity. Non-small cell lung cancer is the most common form of the disease, accounting for 84% of all diagnoses. One ...
Aug 3, 2021
0
348
Medications
Rybrevant approved for some non-small cell lung cancer patients
Rybrevant (amivantamab-vmjw) was approved for adults with non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, the U.S. Food and Drug Administration announced Friday.
May 26, 2021
0
1
Oncology & Cancer
Side effect of cancer treatment can be safely reduced with topical cream
Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study ...
Apr 28, 2021
0
10
Oncology & Cancer
Researchers link cellular transport pathway to aggressive brain cancer
Researchers at McGill University have identified a new cellular pathway that limits the growth and spread of brain tumors by controlling the recycling of cell surface receptor proteins. The study, which will be published ...
Jan 14, 2021
0
6
